Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Boundless Bio
Biotech
J&J vet jumps to Affinia—Chutes & Ladders
J&J vet jumps to Affinia. Astellas shakes up C-suite with exec firings. Pfizer builds oncology team with Legos.
Darren Incorvaia
,
Zoey Becker
Feb 7, 2025 8:30am
Boundless drops clinical-stage cancer drug, shakes up C-suite
Dec 13, 2024 7:30am
Drug shrinks tumors in mice by targeting extrachromosomal DNA
Nov 6, 2024 12:50pm
Boundless Bio makes 'modest' layoffs 5 months after $100M IPO
Aug 13, 2024 4:27am
Boundless boldly goes public with $100M IPO
Mar 28, 2024 7:10am
Boundless Bio eyes $88M offering as spring IPO market blooms
Mar 21, 2024 8:50am